WATSON PHARMACEUTICALS INC's ticker is WPI and the CUSIP is 942683103. A total of 8 filers reported holding WATSON PHARMACEUTICALS INC in Q4 2011. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2012 | $14,141,000 | +16.0% | 164,436 | +14.9% | 1.13% | +19.8% |
| Q3 2012 | $12,190,000 | +15.3% | 143,147 | +0.2% | 0.95% | +10.4% |
| Q2 2012 | $10,569,000 | +13.6% | 142,850 | +3.0% | 0.86% | +17.9% |
| Q1 2012 | $9,305,000 | +11.3% | 138,750 | +0.1% | 0.73% | -0.8% |
| Q4 2011 | $8,360,000 | -43.3% | 138,550 | -47.4% | 0.73% | +3.5% |
| Q3 2011 | $14,738,000 | +5.4% | 263,400 | +3.5% | 0.71% | +9.1% |
| Q2 2011 | $13,983,000 | +100.0% | 254,600 | +103.9% | 0.65% | +14.9% |
| Q1 2011 | $6,993,000 | +8.4% | 124,850 | 0.0% | 0.56% | -0.2% |
| Q4 2010 | $6,449,000 | -5.8% | 124,850 | -23.8% | 0.57% | -12.9% |
| Q1 2010 | $6,848,000 | +57.2% | 163,950 | +49.1% | 0.65% | +51.2% |
| Q4 2009 | $4,355,000 | +7.8% | 109,950 | -0.3% | 0.43% | +4.9% |
| Q3 2009 | $4,040,000 | +19.6% | 110,250 | +10.0% | 0.41% | +1.0% |
| Q2 2009 | $3,377,000 | +20.3% | 100,250 | +11.1% | 0.41% | -2.6% |
| Q1 2009 | $2,808,000 | – | 90,250 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RATIONAL ADVISORS LLC | 263,400 | $14,738,000 | 0.71% |
| BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp | 72,303 | $4,935,000 | 0.06% |
| HUNTINGTON NATIONAL BANK | 19,996 | $1,364,000 | 0.06% |
| SECURIAN ASSET MANAGEMENT, INC | 10,845 | $740,000 | 0.04% |
| MUFG Americas Holdings Corp | 9,850 | $672,000 | 0.02% |